查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1138376

疝氣修復設備的全球市場-2022-2029

Global Hernia Repair Devices Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場動態

對疝氣修復設備開發的資金和投資不斷增加，預計將推動市場增長。

一些公司已經籌集或投資於疝氣修復設備的開發。例如，2020年1月，Virtual Incision Corporation宣布獲得2000萬美元的B+輪融資，由投資者Bluestem Capital領投，回歸投資者PrairieGold Venture Partners和Genesis Innovation Group等相關投資者參投。這筆資金將用於各種應用，包括疝修補術、膽囊切除術、抗反流手術、脾切除術、腎上腺切除術、胃袖、胃旁路術、子宮切除術和肝胰膽管手術 (MIRA)。）將用於支持導致手術機器人平台商業化的監管和臨床計劃。因此，從上述陳述來看，預計將在預測期內推動市場。

與使用疝氣修復設備相關的副作用預計會阻礙市場增長。

市場受到與使用疝氣修復設備相關的副作用的阻礙。在接受疝氣修復裝置治療的患者中觀察到一些副作用，包括疼痛、感染、復發、粘連、腸梗阻和器官穿孔。據英國外科雜誌報導，疝氣網狀塗層減少了一周的粘連。 1 個月後，疝網塗層未觀察到粘連預防。此外，網狀物穿過身體，導致腸梗阻。根據美國食品和藥物管理局 (FDA) 的說法，再生網片是患者腸道前庭形成和梗阻的主要原因。還觀察到慢性感染，例如炎症、發燒和其他類似流感的症狀。根據美國食品和藥物管理局 (FDA) 的說法，Ethicon Physiomesh 植入物在患者之間發生了分層和遷移。這種植入物附著在患者的腸道和皮膚上。這種植入物遷移導致過度疼痛和嚴重損傷。

COVID-19 影響分析

全球疝氣修復設備市場受到 COVID-19 大流行的影響。隨著感染 COVID-19 的患者數量增加，接受疝修補手術的患者數量正在下降。 COVID-19 可能對角膜手術的性能構成嚴重威脅。在全球範圍內，由於接受疝氣修復手術的人數減少，由於 COVID-19 流行，對疝氣修復設備的需求有所下降。根據 F. Kockerling 等人 2020 年的數據，在 COVID-19 中斷的 12 周高峰期間，約有 2800 萬例擇期手術被取消。根據疝氣登記處的數據，由於 COVID-19 流行，腹股溝疝修補術已從 2020 年 2 月的 6,699 例減少到 2020 年 6 月的 3,033 例。臍疝修復從 2020 年 2 月的 1,692 例減少到 2020 年 6 月的 1,421 例。

行業分析

疝氣修復設備市場根據各種行業因素（包括未滿足的需求、定價分析、供應鏈分析和監管分析）對市場進行了深入分析。

全球疝氣修復設備市場報告提供大約 45 多個市場數據表、40 多個數字和 180 頁的組成。

內容

第1章研究方法與範圍

  • 調查方法
  • 調查目的和範圍

第 2 章定義和概述

第 3 章執行摘要

  • 按產品類型劃分的市場細分
  • 按疝氣類型劃分的市場細分
  • 市場細分：按治療區域
  • 按治療類型劃分的市場細分
  • DataM CLO 場景

第 4 章力學

  • 市場影響因素
  • 驅動程序
    • 在疝氣修復手術中越來越多地採用網片
    • 新產品開發
  • 限制因素
    • 網格成本高
    • 產品缺陷風險
  • 商機
  • 影響分析

第5章疝氣修復器械行業分析

  • 波特五力分析
  • 供應鏈分析
  • 定價分析
  • 監管分析
  • 專利分析

第 6 章按產品類型

  • 網格和補丁
    • 天然材料
    • 合成
  • 內窺鏡設備
    • 心電圖儀
    • X 射線
    • 其他
  • 手術設備
    • 縫合
    • 抓手
    • 剪刀
    • 促針因子
    • 其他
  • 其他
    • 植入
    • 存取和解剖裝置
    • 灌溉配件

第 7 章疝型

  • 腹股溝疝
    • 腹股溝直疝
    • 間接腹股溝疝
  • 裂孔疝
  • 臍疝
  • 切口疝
  • 股疝
  • 脊椎疝
  • 腋下/腰椎疝
  • 腹壁疝

第 8 章按治療部位類型

  • 腹部
    • 腹股溝直疝
    • 間接腹股溝疝
  • 大腿上部
  • 腹部
  • 腹股溝

第 9 章治療

  • 腹腔鏡手術
    • 腹股溝直疝
    • 間接腹股溝疝
  • 張緊修復
  • 無張力修復
  • 機器人手術
  • 腹部重建

第 10 章按地區劃分

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第 11 章競爭格局

第 12 章競爭格局

  • 競爭場景
  • 競爭對手戰略分析
  • 產品組合比較分析
  • 市場情況/份額分析
  • 併購分析

第 13 章公司簡介

  • 美敦力公司
    • 公司簡介
    • 產品組合和描述
    • 主要亮點
    • 財務摘要
  • B. Braun Melsungen AG
  • Cook Inc.
  • C.R. Bard
  • Integra Lifesciences Holdings Corporation
  • Baxter International Inc.
  • Cooper Surgical Inc.
  • Lifecell Corporation
  • Stryker Corporation
  • Atrium Medical Corporation

第14章 DataM

簡介目錄
Product Code: DMMD1249

Market Overview

Hernia Repair Devices Market size was valued US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of 5.65% during the forecast period (2022-2029).

Hernia is the condition in which the internal organ or fatty tissue surges out through the fascia, a weak spot present in a surrounding muscle or connective tissue. A hernia occurs most frequently within the abdominal cavity, between the chest and the hips. Inguinal hernia, femoral hernia, umbilical hernia, hiatal hernia, and others are the most prevalent hernia observed across the globe. A hernia is characterized by the signs and symptoms such as swelling in the groin or scrotum, pain at the site of the bulge, pain while lifting, increased bulge size over time, aching sensation, and bowel obstruction.

Hernia repair devices are the devices that are used for performing the surgical procedure for the correction of hernia. Hernia repair devices are used for performing laparoscopic and open repair surgery. The market is dominated by the availability of hernia mesh, including synthetic mesh & biologic mesh, and mesh fixators, including the sutures, tack applicators, and glue applicators.

Market Dynamics

Increasing funding & investment for the development of the Hernia Repair Devices is expected to drive market growth.

Several companies are raising the funding and investment for developing the Hernia Repair Devices. For instance, in January 2020, Virtual Incision Corporation raised USD 20 million in a Series B+ financing round led by the investor Bluestem Capital, with participation from returning investor PrairieGold Venture Partners and Genesis Innovation Group and other affiliated investors. This funding would be used to support the regulatory and clinical programs leading to the commercialization of the miniaturized in vivo robotic assistant (MIRA) Surgical Robotic Platform for various applications such as hernia repair, gallbladder removal, anti-reflux surgery, splenectomy, adrenalectomy, gastric sleeve, gastric bypass, hysterectomy, and hepato-pancreato-biliary procedures. Thus, from the above statements, the market is expected to drive in the forecast period.

Adverse Effects Associated with using Hernia Repair Devices are expected to hamper the market growth.

The market is hindered by the adverse effects associated with the use of hernia repair devices. Several adverse effects were observed among patients treated with hernia repair devices, such as pain, infection, recurrence, adhesion, bowel obstruction, organ perforation, and other adverse effects. According to the British Journal of Surgery, the hernia mesh's coating has reduced the adhesion for a week. There was no adhesion prevention through the hernia mesh coating after a month. Mesh also leads to bowel obstruction as it can migrate in the body. According to the Food and Drug Administration (FDA), the recalled mesh is the leading cause of bowel preformation and obstruction among patients. Chronic infections such as inflammation, fever, and other flu-like symptoms are observed among the patients. According to the Food and Drug Administration (FDA), the Ethicon physiomesh implant was detached and migrated among the patients. This implant was attached to the patient's intestine and the skin. Migration of the implant resulted in excess pain and severe damage.

COVID-19 Impact Analysis

The global hernia repair devices market has been impacted due to the COVID-19 pandemic as there is decreased number of the patients undergoing the hernia repair surgeries with the increasing number of people suffering from the COVID-19. The COVID-19 can be a serious threat for carrying out the corneal surgery. Globally, the demand of the hernia repair devices has reduced due to COVID-19 pandemic with the decrease in the number of the people undergoing the hernia repair surgery. According to the F. Kockerling et.al. 2020, approximately, 28 million elective operations were cancelled during the peak 12 weeks of disruption occurred due to COVID-19. According to the hernia registry, the number of inguinal hernia repair surgery had witnessed the decreased from the 6,699 surgeries in February 2020 to 3033 in June 2020 due to COVID-19 pandemic. The number of the umbilical hernia repair surgeries has decreased from 1, 692 in February 2020 to 1,421 in June 2020.

Industry Analysis

The hernia repair devices market provides in-depth analysis of the market based on various industry factors such as unmet needs, pricing analysis, supply chain analysis, regulatory analysis etc.

Segment Analysis

The hernia mesh segment is expected to hold the largest share in the hernia repair devices market.

The hernia mesh segment accounted for holding the largest share in the hernia repair devices market due to the rising penetration of the hernia mesh. As per Sanders DL et al., yearly, around 20 million prosthetic meshes are implanted among patients with hernias worldwide. Every year nine out of ten hernia surgeries are performed using the hernia mesh in the United States. Hernia mesh supports the damaged tissue around hernias. It can be easily placed around the hernia by attaching it with stitches, staples, or glue. Hernia mesh comprises synthetic materials that can be absorbable, non-absorbable or a combination of both materials found in knitted mesh or non-knitted sheet forms. Hernia mesh is effective in lowering the recurrence of the hernias. The market is dominated by the availability of several hernia mesh products. For instance, Atrium comprises the several hernia mesh product portfolio such as C-QUR, Vitamesh, Proloop, Prolite, and Prolite UltraQ; B. Braun comprises the several hernia mesh portfolio such as Premilene, Omyra, Optilene; LifeCell Corporation comprises the hernia mesh product portfolio such as Alloderm Select, Strattice; and Medtronic comprised of the hernia mesh product portfolio such as Parietex, Permacol, ProGrip, Symbotex, Versatex.

Geographical Analysis

North American region is expected to hold the largest market share in the global hernia repair devices market.

North America dominated the global hernia repair devices market. It accounted for the largest market share in 2021, owing to the increasing adoption of hernia repair devices for performing hernia repair surgeries. According to Raquel Maia et al. 2021, published in Annals of Laparoscopic and Endoscopic Surgery, around 350,000 abdominal wall hernia repair surgeries were performed in a year. There is a high recurrence rate of hernias. The United States accounts for the highest market share due to the availability of favorable reimbursement policies for hernia repair surgeries. There is the presence of several market players developing advanced hernia repair devices. For instance, Ariste Medical gained 510(k) authorization from the US Food and Drug Administration in April 2022 to market their drug-embedded, synthetic hernia mesh in the US.

Competitive Landscape

Major key players in the hernia repair devices market are Medtronic Plc, Ethicon Inc., Atrium, Lifecell Corporation, B Braun Melsungen AG, Baxter International, Inc., Cook Medical, Becton, Dickinson and Company, CooperSurgical Inc., Insightra Medical, Inc., Olympus Corporation, and Integra Lifesciences.

Medtronic Plc:

Overview:

Medtronic plc is an American-Irish registered medical device company primarily operating in the United States. It has an operational and executive headquarters in Fridley, Minnesota, in the US. Moreover, it develops and manufactures devices and therapies to treat more than 30 chronic diseases, including heart failure, Parkinson's disease, urinary incontinence, Down syndrome, obesity, chronic pain, spinal disorders and diabetes. It is operated in 140 countries and employs over 104,950 people.

Product Portfolio:

Dextile Anatomical Mesh: Dextile anatomical mesh offers:

  • 3-D patented anatomical shape conforms with each side of the inguinal anatomy contours.
  • Wide coverage of the myopectineal orifice to minimize the risk of recurrence.
  • Exclusive structure to maintain shape after trocar passage.
  • Large pore size supports excellent tissue ingrowth and visualization of surrounding anatomy during surgery.

The global hernia repair devices market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet By Product type
  • 3.2. Market Snippet By Hernia type
  • 3.3. Market Snippet By Therapeutic area type
  • 3.4. Market Snippet By Treatment type
  • 3.5. DataM CLO Scenario

4. Dynamics

  • 4.1. Market Impacting Factors
  • 4.2. Drivers
    • 4.2.1. Increasing adoption of mesh in hernia repair surgeries
    • 4.2.2. New product developments.
  • 4.3. Restraints
    • 4.3.1. High cost of meshes
    • 4.3.2. Risk of product failures
  • 4.4. Opportunity
  • 4.5. Impact Analysis

5. Hernia Repair Devices Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Patent Analysis

6. By Product type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type Segment
    • 6.1.2. Market Attractiveness Index, By Product type Segment
  • 6.2. Mesh & Patch
    • 6.2.1. Introduction
      • 6.2.1.1. Natural
      • 6.2.1.2. Synthetic
    • 6.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
  • 6.3. Endoscopy Instruments
    • 6.3.1. Electrocardiogram
    • 6.3.2. X-ray
    • 6.3.3. Others
  • 6.4. Surgical Instruments
    • 6.4.1. Sutures
    • 6.4.2. Graspers
    • 6.4.3. Scissors
    • 6.4.4. Needle drivers
    • 6.4.5. Others
  • 6.5. Others
    • 6.5.1. Implants
    • 6.5.2. Access and Dissection devices
    • 6.5.3. Irrigation accessories

7. By Hernia type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Hernia type Segment
    • 7.1.2. Market Attractiveness Index, By Hernia type Segment
  • 7.2. Inguinal hernia
    • 7.2.1. Introduction
      • 7.2.1.1. Direct Inguinal hernia
      • 7.2.1.2. Indirect Inguinal hernia
    • 7.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
  • 7.3. Hiatal hernia
  • 7.4. Umbilical hernia
  • 7.5. Incisional hernia
  • 7.6. Femoral Hernia
  • 7.7. Spigelian Hernia
  • 7.8. Flank/Lumbar Hernia
  • 7.9. Epigastric Hernia

8. By Therapeutic area type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutic area Segment
    • 8.1.2. Market Attractiveness Index, By Therapeutic area Segment
  • 8.2. Abdomen
    • 8.2.1. Introduction
      • 8.2.1.1. Direct Inguinal hernia
      • 8.2.1.2. Indirect Inguinal hernia
    • 8.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
  • 8.3. Upper Thigh
  • 8.4. Belly button
  • 8.5. Groin

9. By Treatment

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Segment
    • 9.1.2. Market Attractiveness Index, By Treatment Segment
  • 9.2. Laparoscopic Surgery
    • 9.2.1. Introduction
      • 9.2.1.1. Direct Inguinal hernia
      • 9.2.1.2. Indirect Inguinal hernia
    • 9.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
  • 9.3. Open Tension Repair
  • 9.4. Non Tension Repair
  • 9.5. Robotic Repair
  • 9.6. Abdominal Wall Reconstruction

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Hernia type
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutic area
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment
    • 10.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Countries
      • 10.2.7.1. The U.S.
      • 10.2.7.2. Canada
      • 10.2.7.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Hernia type
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutic area
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment
    • 10.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Countries
      • 10.3.7.1. Germany
      • 10.3.7.2. U.K.
      • 10.3.7.3. France
      • 10.3.7.4. Italy
      • 10.3.7.5. Spain
      • 10.3.7.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Hernia type
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutic area
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment
    • 10.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Countries
      • 10.4.7.1. Brazil
      • 10.4.7.2. Argentina
      • 10.4.7.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Hernia type
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutic area
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment
    • 10.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Countries
      • 10.5.7.1. China
      • 10.5.7.2. India
      • 10.5.7.3. Japan
      • 10.5.7.4. Australia
      • 10.5.7.5. Rest of Asia Pacific
  • 10.6. The Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Hernia type
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutic area
    • 10.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment

11. Competitive Landscape

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Competitor Strategy Analysis
  • 12.3. Comparative Product Portfolio Analysis
  • 12.4. Market Positioning/Share Analysis
  • 12.5. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. Medtroinc Plc
    • 13.1.1. Company overview
    • 13.1.2. Product portfolio and description
    • 13.1.3. Key highlights
    • 13.1.4. Financial overview
  • 13.2. B. Braun Melsungen AG
  • 13.3. Cook Inc.
  • 13.4. C.R. Bard
  • 13.5. Integra Lifesciences Holdings Corporation
  • 13.6. Baxter International Inc.
  • 13.7. Cooper Surgical Inc.
  • 13.8. Lifecell Corporation
  • 13.9. Stryker Corporation
  • 13.10. Atrium Medical Corporation

14. DataM Intelligence

  • 14.1. Appendix
  • 14.2. About Us and Services
  • 14.3. Contact Us